Laura Spiers

476 total citations
15 papers, 321 citations indexed

About

Laura Spiers is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Laura Spiers has authored 15 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Cancer Research. Recurrent topics in Laura Spiers's work include Ultrasound and Hyperthermia Applications (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Laura Spiers is often cited by papers focused on Ultrasound and Hyperthermia Applications (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Laura Spiers collaborates with scholars based in United Kingdom and United States. Laura Spiers's co-authors include Miranda Payne, Nicholas Coupe, Avinash Gupta, Joachim Hagel, Paul Miller, Leonard W. Seymour, Joshua D. Freedman, Ioannis Psallidas, Rebecca Ashfield and Nikolaos I. Kanellakis and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Laura Spiers

15 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Spiers United Kingdom 7 248 91 90 59 41 15 321
Adel Samson United Kingdom 12 244 1.0× 155 1.7× 164 1.8× 135 2.3× 50 1.2× 30 422
Aygul Valiullina Russia 10 259 1.0× 170 1.9× 69 0.8× 148 2.5× 26 0.6× 17 412
Amirhossein Mardi Iran 11 190 0.8× 164 1.8× 62 0.7× 129 2.2× 24 0.6× 30 411
Sanaa Tahiri United States 9 327 1.3× 143 1.6× 81 0.9× 85 1.4× 61 1.5× 15 436
Ekaterina Zmievskaya Russia 10 291 1.2× 166 1.8× 75 0.8× 177 3.0× 38 0.9× 18 452
Xiafang Chen China 11 86 0.3× 138 1.5× 101 1.1× 70 1.2× 41 1.0× 34 306
Irina Ganeeva Russia 9 216 0.9× 130 1.4× 56 0.6× 132 2.2× 27 0.7× 16 344
Houli Zhao China 10 275 1.1× 100 1.1× 75 0.8× 66 1.1× 16 0.4× 24 338
Ruimin Hong China 9 283 1.1× 127 1.4× 72 0.8× 75 1.3× 19 0.5× 29 355
Diego Adrianzen Herrera United States 10 125 0.5× 68 0.7× 31 0.3× 71 1.2× 49 1.2× 41 321

Countries citing papers authored by Laura Spiers

Since Specialization
Citations

This map shows the geographic impact of Laura Spiers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Spiers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Spiers more than expected).

Fields of papers citing papers by Laura Spiers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Spiers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Spiers. The network helps show where Laura Spiers may publish in the future.

Co-authorship network of co-authors of Laura Spiers

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Spiers. A scholar is included among the top collaborators of Laura Spiers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Spiers. Laura Spiers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Poirier, Miriam C., et al.. (2023). Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival. Frontiers in Immunology. 14. 1289313–1289313. 12 indexed citations
2.
3.
Gray, Michael, Laura Spiers, & Constantin Coussios. (2023). Sound speed and attenuation of human pancreas and pancreatic tumors and their influence on focused ultrasound thermal and mechanical therapies. Medical Physics. 51(2). 809–825. 1 indexed citations
4.
Gray, Michael, Laura Spiers, & Constantin Coussios. (2022). Effects of human tissue acoustic properties, abdominal wall shape, and respiratory motion on ultrasound-mediated hyperthermia for targeted drug delivery to pancreatic tumors. International Journal of Hyperthermia. 39(1). 918–934. 6 indexed citations
5.
Kazmi, Farasat, Shibani Nicum, René L. Roux, et al.. (2021). A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer. Clinical Cancer Research. 27(11). 3028–3038. 4 indexed citations
6.
Zhang, Shuai, Laura Spiers, Ali Abdulnabi Suwaidan, et al.. (2020). Impact of age on the toxicity of immune checkpoint inhibition. Journal for ImmunoTherapy of Cancer. 8(2). e000871–e000871. 62 indexed citations
7.
Spiers, Laura, Nicholas Coupe, & Miranda Payne. (2019). Toxicities associated with checkpoint inhibitors—an overview. Lara D. Veeken. 58(Supplement_7). vii7–vii16. 75 indexed citations
8.
Blagden, Sarah P., Ivana Rizzuto, Markand Patel, et al.. (2018). Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study. British Journal of Cancer. 119(7). 815–822. 33 indexed citations
9.
Zhang, Shuai, Laura Spiers, Zayd Tippu, et al.. (2018). The impact of patient age on toxicity and efficacy of immunotherapy agents.. Journal of Clinical Oncology. 36(15_suppl). e15116–e15116. 2 indexed citations
10.
Blagden, Sarah P., Pavlina Spiliopoulou, Laura Spiers, et al.. (2018). A phase I first-in-human, dose-escalation and expansion study to evaluate the safety and tolerability of NUC-3373 in patients with locally advanced, unresectable or metastatic solid malignancies. Annals of Oncology. 29. viii145–viii145. 2 indexed citations
11.
Ghazaly, Essam, Victoria K. Woodcock, Laura Spiers, et al.. (2017). Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors. Annals of Oncology. 28. v128–v128. 4 indexed citations
12.
Blagden, Sarah P., Laura Spiers, Victoria K. Woodcock, et al.. (2017). PRO-002, a phase Ib dose-escalation study of NUC-1031 with carboplatin for recurrent ovarian cancer. Annals of Oncology. 28. v345–v345. 2 indexed citations
13.
Freedman, Joshua D., Joachim Hagel, Eleanor M. Scott, et al.. (2017). Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies. EMBO Molecular Medicine. 9(8). 1067–1087. 100 indexed citations
14.
Spiers, Laura, et al.. (2015). Recognition of the deteriorating patient. BMJ Quality Improvement Reports. 4(1). u206777.w2734–u206777.w2734. 2 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adel Samson Breakdown of academic impact, for papers by Aygul Valiullina Breakdown of academic impact, for papers by Amirhossein Mardi Breakdown of academic impact, for papers by Sanaa Tahiri Breakdown of academic impact, for papers by Ekaterina Zmievskaya Breakdown of academic impact, for papers by Xiafang Chen Breakdown of academic impact, for papers by Irina Ganeeva Breakdown of academic impact, for papers by Houli Zhao Breakdown of academic impact, for papers by Ruimin Hong Breakdown of academic impact, for papers by Diego Adrianzen Herrera
Rankless by CCL
2026